{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:11:30Z","timestamp":1789517490946,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1067\/mai.2000.106040","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:21:43Z","timestamp":1027570903000},"page":"917-922","source":"Crossref","is-referenced-by-count":237,"title":["Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial"],"prefix":"10.1067","volume":"105","author":[{"given":"Eli O.","family":"Meltzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Malmstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Prenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn X.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore F.","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2000.106040_bib1","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/S0091-6749(97)80040-1","article-title":"Prevalence of allergic rhinitis in the United States","volume":"99","author":"Nathan","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.106040_bib2","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1016\/S0091-6749(97)80041-3","article-title":"Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires","volume":"99","author":"Meltzer","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.106040_bib3","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1016\/S0091-6749(97)90000-2","article-title":"Measuring health-related quality of life in rhinitis","volume":"99","author":"Juniper","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.106040_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2500\/105065897782537142","article-title":"Treatment strategies designed to minimize medical complications of allergic rhinitis","volume":"11","author":"Fireman","year":"1997","journal-title":"Am J Rhinol"},{"key":"10.1067\/mai.2000.106040_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/07853899608999069","article-title":"Treatment of allergic rhinitis","volume":"28","author":"Suonpaa","year":"1996","journal-title":"Ann Med"},{"key":"10.1067\/mai.2000.106040_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000237289","article-title":"Pathophysiology of allergic rhinitis","volume":"110","author":"Bousquet","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1067\/mai.2000.106040_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2000.106040_bib8","first-page":"279","article-title":"Leukotrienes as mediators of nasal inflammation","volume":"22","author":"Knapp","year":"1994","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1067\/mai.2000.106040_bib9","first-page":"449","article-title":"Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro","volume":"126","author":"Marom","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1067\/mai.2000.106040_bib10","first-page":"537","article-title":"The role of leukotriene D4 in allergic rhinitis","volume":"60","author":"Okuda","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1067\/mai.2000.106040_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2000.106040_bib12","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1164\/ajrccm\/143.5_Pt_2.S91","article-title":"The role of leukotrienes in allergic rhinitis: a review","volume":"143","author":"Naclerio","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1067\/mai.2000.106040_bib13","first-page":"304","article-title":"Cysteinyl leukotrienes in asthma: old mediators up to new tricks","volume":"16","author":"Hay","year":"1995","journal-title":"TIPS"},{"key":"10.1067\/mai.2000.106040_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2222.1996.tb00621.x","article-title":"The role of leukotrienes in asthma and allergic rhinitis","volume":"26","author":"Busse","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2000.106040_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y95-028","article-title":"Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist","volume":"73","author":"Jones","year":"1994","journal-title":"Can J Physiol Pharm"},{"key":"10.1067\/mai.2000.106040_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","article-title":"Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma; a multicenter, randomized, double-blind trial","volume":"150","author":"Reiss","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1067\/mai.2000.106040_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199753020-00006","article-title":"Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis","volume":"53","author":"Jeal","year":"1997","journal-title":"Drugs"},{"key":"10.1067\/mai.2000.106040_bib18","series-title":"Histamine and H1-receptor antagonists in allergic disease","author":"Simons","year":"1996"},{"key":"10.1067\/mai.2000.106040_bib19","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1164\/ajrccm.151.6.7767514","article-title":"The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis","volume":"151","author":"Donnelly","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1067\/mai.2000.106040_bib20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","article-title":"Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor","volume":"323","author":"Knapp","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2000.106040_bib21","first-page":"A416","article-title":"Montelukast, a leukotriene-receptor antagonist, in combination with loratadine, an H1-receptor antagonist, in the treatment of chronic asthma; a multicenter, randomized double-blind study","volume":"157","author":"Reicin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1067\/mai.2000.106040_bib22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.155.6.9196086","article-title":"Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics","volume":"155","author":"Roquet","year":"1997","journal-title":"Am J Respir Crit Care"},{"key":"10.1067\/mai.2000.106040_bib23","first-page":"407","article-title":"Safety and efficacy of loratadine (Sch-29851): a new nonsedating antihistamine in seasonal allergic rhinitis","volume":"58","author":"Dockhorn","year":"1987","journal-title":"Ann Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900800147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900800147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:21:20Z","timestamp":1557400880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674900800147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0091674900800147"],"URL":"https:\/\/doi.org\/10.1067\/mai.2000.106040","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}